British researchers have linked higher consumption of ultra-processed foods to an increased risk of developing and dying from cancer.
Asher Biotherapeutics Inc has expanded its manufacturing agreement with Lonza to include the manufacturing of AB248.
Strategic planning for the development of a novel therapy is critically important to reduce financial burdens, save time, and find the best, shortest path forwards. No two products will have the same pathway or same criterion for optimisation, but early, forward-looking planning can result in greater efficiency and a better understanding of key decisions and timepoints along the course of novel therapy development.
Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies.
pixabay.com/SD-PicturesA new study adds weight to ongoing legal and political investigations against ExxonMobil for deliberate climate malfeasance.
With Sunstone Life Siences A/S as a new investor, Belgian remyelination specialist Rewind Therapeutics has increased its 2018 Series A funding.
British researchers have created a new polymer material that may help to prevent urinary tract infections caused by catheters
Bioplastics specialist Avantium N.V. has inked a 5-year agreement to supply Henkel with plant sugar based furandicarboxylic acid , a building block of PEF bioplastics.
Maintaining the integrity of tumour biomarkers during processing and storage is of great importance for the accurate diagnosis and prognosis of many diseases, including cancers. To safely store samples for research or clinical uses, freezing procedures are used to arrest the degradation of biomarkers. However, the stability of these molecules depends upon long-term storage conditions.
InDevR Inc., a provider of analytical technologies for vaccines and biotherapeutics, has raised $9m in Series B financing.